Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity - Top-Institutions - MDSpire

Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity

  • By

  • Husheem Michael

  • Michael Pitre

  • Gene W. Weng

  • Mikaela M. Vallas

  • Ellen Chen

  • Paul Sheiffele

  • Wei Weng

  • June 17, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Immunology
    • Oncology

  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, California

    Key Differentiators

    • Immunology
    • Oncology

Original Source(s)

Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity

  • by Husheem Michael, Michael Pitre, Gene W. Weng, Mikaela M. Vallas, Ellen Chen, Paul Sheiffele, Wei Weng

  • June 17, 2026

Related Content

Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies

Decoding autoimmune disease with single-cell immune repertoire and transcriptome sequencing: mechanisms and therapeutic opportunities

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study